If you're having problems viewing this message, please click here for additional help.
Asterand's Human Insight Newsletter
 June, 2010                                                                                                                                              Home
Pathologist-Verified Biospecimens Identify Renal Cell Carcinoma Protein Biomarkers
Asterand pathologists recently developed and presented a scientific poster at the International Society for Biological and Environmental Repositories (ISBER) 2010 Annual Meeting, held May 11-14 in Rotterdam, The Netherlands. The poster presentation detailed the advantages of utilizing pathologist-verified biospecimens in the identification of Renal Cell Carcinoma protein biomarkers in human blood.

To view the poster abstract, click here.

To view the poster, click here.

For further information, please e-mail: advantage@asterand.com.
ASTERAND PLC IS THE LEADING GLOBAL SUPPLIER OF HUMAN TISSUE AND HUMAN TISSUE-BASED RESEARCH SERVICES TO PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ENGAGED IN DRUG DISCOVERY AND DEVELOPMENT.

Asterand, Inc. (US Laboratory) , TechOne Suite 501 , 440 Burroughs , Detroit, MI 48202-3420 U.S.A. , 313.263.0960
Asterand UK Limited (UK Laboratory) , 2 Orchard Road , Royston,Hertfordshire, SG8 5HD, UK , +44 (0)1763 211600
BioSeek, Inc., 310 Utah Avenue, Suite 100, South San Francisco, California 94080, 650.416.7600
newsletter@asterand.com To unsubscribe click here